Use of ranolazine in chronic stable angina patients and patients with type 2 diabetes mellitus – Summary of CARISA, MARISA & TERISA trials
Managing chronic stable angina pectoris continues to represent a challenge to the practicing physician. Novel anti-angina agents have been incorporated to our therapeutic arsenal in recent years. Ranolazine is one of such agents with novel mechanisms of actions. This programme focuses on the indications, contraindications and practical use of this agent in clinical practice. General practitioners, hospital consultants and clinical-academics contribute their expert views and practical suggestions in this online educational programme.
Related articles
10/14/2018 - Omega-6 vegetable oils and coronary artery disease: The silent assassin - Sian Claire Owen, medical journalist for Cardio Debate, UK
04/09/2018 - Estimating the potential incremental benefit of treating CAD patients with PCSK9 inhibitors - Prof JC Kaski, St George's, University of London, UK
03/26/2018 - Coronary artery by-pass surgery versus coronary stenting for management of multivessel coronary artery disease – And the winner is… - Prof JC Kaski, St George's, University of London, UK
01/15/2018 - Percutaneous Coronary Intervention (PCI): a therapeutic myth? - Prof JC Kaski, St George's, University of London, UK
12/10/2017 - Male-pattern baldness and premature greying increases heart disease risk ‘five fold’ - Sian C. Owen, Medical Writer for Cardio Debate
06/07/2017 - The impact of childhood obesity can last well into adulthood - Sian Claire Owen, Medical Journalist for Cardio Debate
01/02/2017 - Recurrent or persistent angina after coronary artery revascularisation and stent implantation - Prof Juan Carlos Kaski, St George's, University of London, UK
11/07/2016 - The role of the gut microbiota in the treatment and prevention of cardio-metabolic diseases - Prof Juan Carlos Kaski, St George's, University of London, UK
10/25/2016 - Happy Heart Syndrome - Prof Juan Carlos Kaski, St George's, University of London, UK
10/17/2016 - Cardiac imaging in CAD: Too much of a good thing? - Prof Udo Sechtem, Robert-Bosch Hospital, Stuttgart, Germany
Leave a Reply
You must be logged in to post a comment.